Suppr超能文献

评估糖尿病视网膜病变管理的直接、间接医疗和社会成本:系统综述。

Determining direct, indirect healthcare and social costs for diabetic retinopathy management: a systematic review.

机构信息

Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.

National Centre for Disease Control, Tripoli, Libya.

出版信息

BMC Ophthalmol. 2024 Sep 30;24(1):424. doi: 10.1186/s12886-024-03665-6.

Abstract

INTRODUCTION

Diabetic retinopathy (DR) is a rapidly growing global public health threat; it affects 1 in 3 people with diabetes and is still the leading cause of blindness among the working-age population. The management of diabetic retinopathy is becoming more advanced and effective but is highly expensive compared to other ocular diseases.

AIM

To report direct medical, indirect medical, and nonmedical costs of diabetic retinopathy in developed and developing countries through a systematic review.

METHODS

Related articles published in the PubMed, Google Scholar, and EMBASE electronic databases from 1985 to 2022 were identified using the keywords direct medical and indirect medical and social costs of diabetic retinopathy. However, previous systematic reviews, abstracts, and case reports were excluded.

RESULTS

Thirteen articles were eligible for assessing the economic burden of diabetes management and its complications. Our analysis revealed that increasing prevalence and severity of diabetic retinopathy (DR) are associated with higher direct and indirect healthcare expenditures. The impact of DR on working-age adults, leading to irreversible blindness in advanced stages, underscores the urgent need for cost-effective prevention and management strategies.

DISCUSSION

This study systematically reviewed the direct medical, indirect medical, and nonmedical costs of DR in developed and developing countries. Our findings highlight the significant economic burden of DR, emphasizing the importance of implementing effective prevention and management measures to alleviate costs and enhance patient outcomes.

CONCLUSION

The substantial financial burden of DR necessitates a re-evaluation of current screening and management programs. Revision of these programs is crucial to improve quality of care, reduce costs, and ultimately achieve Sustainable Development Goal 3, which aims to ensure good health and well-being for all.

摘要

简介

糖尿病视网膜病变(DR)是一种迅速增长的全球公共卫生威胁;它影响了每 3 个糖尿病患者中的 1 个,仍然是工作年龄人群致盲的主要原因。与其他眼部疾病相比,糖尿病视网膜病变的管理变得更加先进和有效,但费用也高得多。

目的

通过系统评价报告发达国家和发展中国家糖尿病视网膜病变的直接医疗、间接医疗和非医疗成本。

方法

使用糖尿病视网膜病变直接医疗和间接医疗及社会成本的关键词,在 PubMed、Google Scholar 和 EMBASE 电子数据库中检索 1985 年至 2022 年发表的相关文章。但排除了先前的系统评价、摘要和病例报告。

结果

有 13 篇文章符合评估糖尿病管理及其并发症经济负担的标准。我们的分析表明,糖尿病视网膜病变(DR)的患病率和严重程度增加与直接和间接医疗保健支出的增加有关。DR 对工作年龄成年人的影响,导致在晚期不可逆转的失明,突显了制定具有成本效益的预防和管理策略的迫切需要。

讨论

本研究系统地回顾了发达国家和发展中国家 DR 的直接医疗、间接医疗和非医疗成本。我们的研究结果强调了 DR 的巨大经济负担,强调了实施有效预防和管理措施以减轻成本和改善患者预后的重要性。

结论

DR 的巨大财务负担需要重新评估当前的筛查和管理计划。对这些计划的修订对于提高医疗质量、降低成本以及最终实现可持续发展目标 3 至关重要,该目标旨在确保所有人的良好健康和福祉。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ca/11441148/d71fbb481fd5/12886_2024_3665_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验